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Antibiotics are chemotherapeutic agents, which have been a very powerful tool in the
clinical management of bacterial diseases since the 1940s. However, beneﬁts offered
by these magic bullets have been substantially lost in subsequent days following the
widespread emergence and dissemination of antibiotic-resistant strains.While it is obvious
that excessive and imprudent use of antibiotics signiﬁcantly contributes to the emergence
of resistant strains, antibiotic resistance is also observed in natural bacteria of remote
places unlikely to be impacted by human intervention. Both antibiotic biosynthetic genes
and resistance-conferring genes have been known to evolve billions of years ago, long
before clinical use of antibiotics. Hence it appears that antibiotics and antibiotics resistance
determinants have some other roles in nature, which often elude our attention because
of overemphasis on the therapeutic importance of antibiotics and the crisis imposed by
the antibiotic resistance in pathogens. In the natural milieu, antibiotics are often found to
be present in sub-inhibitory concentrations acting as signaling molecules supporting the
process of quorum sensing and bioﬁlm formation. They also play an important role in the
production of virulence factors and inﬂuence host–parasite interactions (e.g., phagocytosis,
adherence to the target cell, and so on). The evolutionary and ecological aspects of
antibiotics and antibiotic resistance in the naturally occurring microbial community are
little understood. Therefore, the actual role of antibiotics in nature warrants in-depth
investigations. Studies on such an intriguing behavior of the microorganisms promise
insight into the intricacies of the microbial physiology and are likely to provide some lead
in controlling the emergence and subsequent dissemination of antibiotic resistance. This
article highlights some of the recent ﬁndings on the role of antibiotics and the genes that
confer resistance to antibiotics in nature.
Keywords: antibiotics, sub-inhibitory concentration, quorum sensing, virulence, stress response, antibiotic
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INTRODUCTION
The term “antibiotics” was ﬁrst coined by the American microbi-
ologist Selman Waksman and his colleagues to describe chemical
substances produced by microorganisms and having antagonis-
tic effects on the growth of other microorganisms. It excluded
synthetic antimicrobials (sulfur drugs) and biological products
of non-microbial origin having antagonistic effects on bacteria.
Though antibiotics were introduced into the clinical practice only
in the middle of the last century, the use of microorganisms for
the management of microbial infections in ancient Egypt, Greece,
China, and some other places of the world is well-documented.
The modern era of antibiotics started with the serendipitous dis-
covery of penicillin from the culture ﬁltrate of a fungus,Penicillium
notatum by Alexander Fleming in 1928 (Fleming, 1929).
In the present scenario, antibiotics available in the market
are either produced by microbial fermentation or are derived
via semi-synthetic route using the existing antibiotic backbone
structure. They are classiﬁed into different chemically deﬁned
groups. Antibiotics target bacterial physiology and biochemistry,
causing microbial cell death or the cessation of growth. A signiﬁ-
cant number of these antibiotics affect cell walls or membranes
(e.g., β-lactam and glycopeptides), while several others exert
their antibacterial activity by targeting protein synthetic machin-
ery via interaction with ribosomal subunits and these include
antibiotics such asmacrolides, chloramphenicol, tetracycline, line-
zolid, and aminoglycosides. Other “mechanistic” groups include
molecules which interfere with the nucleic acid synthesis [e.g.,
ﬂuoroquinolones (FQ) and rifampin], while some others exert
their effects by interfering with the metabolic pathways (e.g.,
sulphonamides and folic acid analog) or by disruption of the bac-
terial membrane structure (e.g., polymyxins, daptomycin, and
others).
A surge of discovery of several such antibacterial and antifungal
antibiotics accompanied with a new generation of semi-synthetic
drugs initially led to euphoria that any infectious disease could be
successfully controlled using antibiotics. However, emergence and
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propagation of bacterial strains, resistant to almost all the thera-
peutically useful antibiotics during the past few decades revealed
the limitation of the wonder drugs. Though imprudent and exces-
sive use of antibiotics is highlighted as a major causative factor
behind the setback, it is evident by this time that antibiotic resis-
tance does not call for exposure of the organisms to antibiotics.
It is also found that genes involved in the biosynthesis of antibi-
otics and antibiotic resistance evolved thousands of years before
antibiotics were introduced into the clinical practice. Hence both
antibiotic and its resistance determinants have some other role in
bacterial physiology.
ROLE OF ANTIBIOTICS IN NATURE
Antibiotics in the biosphere are produced by microorganisms as
secondary metabolites at a concentration much lower than the
therapeutic dose. Waksman was convinced that antibiotics play
“no real part in modifying or inﬂuencing living processes that
occur in nature” (Waksman, 1961) though there is evidence to
the contrary (Gullberg et al., 2011). Antibiotics are produced in
the late stages of microbial stationary growth phase, decoupled
from the doubling time, implying that they are not indispens-
able for sustenance of life of the producer organism. However,
it is also a fact that the production of an antibiotic is a multi-
step process that involves a number of genes. Hence it does not
seem tenable that such a complex anabolic process has been sus-
tained through evolution without having any obvious purpose to
serve. Recent studies reveal that antibiotics do have some speciﬁc
effects on the natural milieu of the microbes while they assume
an entirely different role as antibacterial agents in the dose used
in therapeutics. This dual role of antibiotics remains a riddle.
In the natural habitat, the diverse microbial communities exist
as a multi-cellular network. They constitute a huge reservoir of
different metabolic activities and have to evolve continuously to
encounter the constant environmental threat and different selec-
tion pressure. Survival is most often a major challenge because of
the limiting nutrients. Under nutrient starvation, the organisms
start secreting secondary metabolites, which are a diverse array
of low molecular weight organic molecules, known as the par-
vome (Davies, 2009). The total number of parvome detected so
far is at least an order of magnitude larger than the number of
bacteria in the biosphere. Bacteria of the phylum Actinobacteria
(Ventura et al., 2007), a huge taxonomic group of diverse gen-
era with a high genomic guanine–cytosine (GC) content, produce
millions of complex bioactive small molecules. The ecological role
of the majority of these small molecules in nature remains largely
unknown.Amongst thesemolecules, only a fractionhas been iden-
tiﬁed to have antibiotic activity and has been extensively studied
only from the therapeutic point of view whereas the signiﬁcance
of antibiotics in nature still remains a mystery. The prevail-
ing confusion about its role in nature has been dealt by Julian
Davis in an article titled: “are antibiotics naturally antibiotic?”
(Davies, 2006).
ROLE OF ANTIBIOTICS IN INTERSPECIES COMPETITION
Antibiotics are critical to the producer organisms in the natural
environment as they are needed both for survival and competi-
tive advantage. Thus antibiotics are widely perceived as an arsenal
of the producer microorganisms that they use against other nat-
urally occurring cohabiting microorganisms and eliminate these
competing bacteria for the purpose of “empire building” in the
microbial community (Davies, 1990). The concept of the empire
building role of antibiotics stemmed from the soil borne nature
of the antibiotic-producing microorganisms. In certain instances
like plant–microbe interactions, the antibiotic-producing organ-
isms have indeed been found to secrete antibiotics to eliminate the
competing bacteria in the vicinity. Pseudomonas ﬂuorescens 2-79
(NRRL B-15132) colonizing the rhizosphere of wheat, secrete the
antibiotic, phenazine which inhibits the growth of Gaeumanno-
myces graminis var. tritici thus suppressing a major root and crown
disease of wheat and barley (Thomashow and Weller, 1988). Few
other ecological examples of probable antibiotic function of these
secondary metabolites in nature include the fungus-growing ants,
which carry an antibiotic-producing actinomycete (Pseudonocar-
dia sp.) on their cuticle speciﬁcally for biocontrol of the fungal
garden parasite, Escovopsis sp. (Currie et al., 1999; Cafaro and
Currie, 2005). Another example is the antibiotic-producing strain
Streptomyces diastatochromogenes strain PonSSII controlling the
growth of Streptomyces scabies strain RB4, the causative agent of
potato scab (Neeno-Eckwall et al., 2001).
ROLE OF ANTIBIOTICS AS SIGNALING MOLECULES
During primordial development, the cells instead of antagonizing
each other remained in a communal harmony to share an evo-
lutionary advantage and the symbiotic coexistence of microbes
in bioﬁlms, in lichens and in a metabolically quiescent state is
well-documented (Davies, 2006). Chemical communication, an
essential feature in such mixed populations, helps the microor-
ganisms coordinate with each other in an orchestrated fashion.
Probably the small molecule antibiotics act as a liaison in the com-
munication between the microbes. It has been postulated that
antibiotics in the early stages of biochemical evolution had some
functions mediated by their interaction with primitive macro-
molecule receptors. Later on, many of these low molecular weight
interacting partners were employed to antagonize the original
receptor sites in macromolecular structure thus imparting the
antibiosis property. Such a switchover in the role of the pri-
mordial effector molecule has been hypothesized in a schematic
biochemical pathway by J. Davies (Davies, 1990). During the past
seven decades, the scientists were mostly preoccupied with study-
ing the antibiotic property of these small molecules because of
its overwhelming success in pharmacotherapy. Only during the
recent past antibiotics were implicated in several other physi-
ological phenomena ranging from control of transcription and
translation to growth of the producer organism in the microbial
communities. From a broader perspective of evolutionary and
ecological point of view, antibiotics, apart from having a growth
inhibitory activity, appear to have a role in intra- and inter-domain
communication in various ecosystems. Under normal physiologi-
cal condition, microorganisms in their marine and soil habitats
produce antibiotics at sub-minimum inhibitory concentration
(sub-MIC). Despite having evidence that resistant bacteria repre-
senting a low fraction in a sample were enriched at sub-inhibitory
concentrations of three clinically useful antibiotics (Gullberg et al.,
2011), antibiotics are believed not to display any antibiotic activity
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at concentrations lower than 1/100 of the minimum inhibitory
concentrations (Davies, 2006). Instead, many antibiotics are
known topossess biological activities other than the inhibitory role
at such a low concentration and have major effects on global tran-
scription pattern. Antibiotics such as erythromycin (an inhibitor
of translation) and rifampicin (an inhibitor of transcription), at
low concentrations, could modulate global bacterial transcription
pattern in a random promoter library construct of Salmonella
typhimuriumhaving lux as the reporter gene. In response to the low
concentration of different antibiotics, a variety of promoters were
activated, including those involved in virulence, metabolic, and
adaptive functions. However, transcription was markedly reduced
in antibiotic-resistant hosts but the mutants defective in stress
responses such as rec and lex (SOS), dnaJ and ΔdnaKJ (heat shock
response), and ΔrelA ΔspoT (universal stress response) could not
prevent antibiotic-induced modulation of transcription pattern at
sub-inhibitory concentration (Gohet al.,2002). Antibiotics having
different binding sites on the ribosome (chloramphenicol, amino-
glycosides, macrolides, and tetracycline), or intruding into the
process of cell-wall synthesis (some β-lactams and fosfomycin)
were reported to alter the transcription pattern under different
circumstances. So it has been postulated that the transcription
machinery must be capable of sensing these subtle variations in
the conformation or stoichiometry of small molecule antibiotics
to respond to speciﬁc up- or downregulation.
These small molecules have a signiﬁcant role in the dynam-
ics of bacterial communities in nature, thus contributing to both
competitive and interactive responses. Inhibition occurs when
high concentrations are attained, transcriptional changes occur
at low concentrations (Davies et al., 2006). This dose-dependent
dual role, deﬁned as hormesis, is not exclusively associated with
antibiotics but also found in different other biomolecules (Davies
et al., 2006; Calabrese, 2009). The dual role of antibiotics has been
conﬁrmed by the detection of a variety of bioactivities of several
antibiotics. Some β-lactam antibiotics were shown to stimulate the
glutamate transporter-1 (GLT1) both in cell culture and in animal
models (Rothstein et al., 2005). Thiostrepton, a potent protein
synthesis inhibitor which binds to 23S RNA, was found to act as a
transcription inducer at a concentration lower than the inhibitory
concentration (Murakami et al., 1989). Lincomycin, which termi-
nates the peptide bond elongation, could stabilize certain mRNAs
like the bla mRNA (Matsushita et al., 1989). Puromycin, in spite
of having a chain termination activity in polypeptide synthesis,
can affect nucleic acid synthesis, mediated by its aminonucleo-
side moiety (Yarmolinsky and Haba, 1959). Edeine, apart from its
inhibitory role in protein synthesis, has speciﬁc effects on nucleic
acid synthesis (Kurylo-Borowska and Szer, 1972). Many of the so-
called antibiotics have been shown to have sex pheromone activity
and found to stimulate bacterial conjugation by several orders
of magnitude (Evans and Dyke, 1988). Sub-MICs of antibiotics
are thus known to induce extensive transcriptional changes in
bacteria (Tsui et al., 2004; Yim et al., 2006a). In the majority of
cases the underlying mechanisms of the different ecological role
of the antibiotics at sub-inhibitory concentration still remain to
be elucidated.
A second level of signaling via antibiotics has also been doc-
umented in different organisms. Cationic peptides, which have
a broad range of antimicrobial activities against most Gram-
negative and Gram-positive bacteria, fungi, enveloped viruses,
and eukaryotic parasites, also have a broad spectrum of pro-
inﬂammatory and anti-inﬂammatory effects on the host immune
system. Apart from their antimicrobial activity, these molecules
also act as transcription modulators. Cecropin, an insect-derived
cationic peptide, was shown to alter the transcription pattern of
26 genes when added to Escherichia coli (Hong et al., 2003). Some
cationic peptides of microbial- and mammalian origin (polymyx-
ins B and E, cattle indolicidin and human LL-37) were found to
activate the two component pmrA–pmrB regulatory operon,which
regulates the resistance to polymyxin B and cationic antimicro-
bial peptides in Pseudomonas aeruginosa (McPhee et al., 2003).
Inhibitory effect of several antibiotics on sporulation of bacteria
is well-known (Ochi and Freese, 1983; Babakhani et al., 2012).
ROLE OF ANTIBIOTICS IN VIRULENCE
Some antibiotics, at concentrations below the MIC, are able to
modulate the expression of some genes associated with virulence.
Up- and downregulation of the transcription of virulence and
motility genes were induced by the RNA polymerase inhibitor,
rifampicin (Yim et al., 2006b). Sub-inhibitory concentration of
several other antibiotics such as metronidazole, vancomycin, clin-
damycin, and linezolid could induce the early transcription of
tcdA (toxin A) and tcdB (toxin B), the major virulence factors-
encoding genes of Clostridium difﬁcile, a nosocomial pathogen
responsible for diarrhea, during exponential phase growth of the
organism (Gerber et al., 2008). Imipenems, at sub-inhibitory con-
centration, were shown to induce β-lactamase and production
of alginate during bioﬁlm formation in Pseudomonas aeruginosa.
Sub-inhibitory concentration of an aminoglycoside antibiotic
tobramycin induced bioﬁlm formation in Pseudomonas aerugi-
nosa andEscherichia coli (Hoffman et al., 2005). On the other hand,
sub-inhibitory level of the macrolide antibiotic azithromycin was
shown to elicit the exactly opposite phenomenon like suppression
of the alginate overproduction and bioﬁlm formation in Pseu-
domonas aeruginosa (Ichimiya et al., 1996). These contradictory
observations suggest that the molecular targets of different antibi-
otics for the execution of their inhibitory effects could be similar
but they might differ extensively while functioning as signaling
molecules (Aminov, 2009). This postulation is substantiated by
the fact that tobramycin at sub-inhibitory concentrations does
not bind the ribosome (the usual target for its role as an antibi-
otic), rather it targets the aminoglycoside response regulator gene
(arr) which is responsible for the induction of bioﬁlm-speciﬁc
aminoglycoside resistance. The gene is also predicted to encode
an inner-membrane phosphodiesterase acting on the substrate,
cyclic di-guanosine monophosphate (c-di-GMP), a bacterial sec-
ond messenger that regulates cell surface adhesiveness (Hoffman
et al., 2005).
The inﬂuence of sub-inhibitory doses of several antibiotics on
the expression of the gene encoding the Staphylococcus aureus
alpha-toxin (hla), a major virulence factor of the pathogen,
revealed that glycopeptide antibiotics had no effect whereas β-
lactams induced a strong expression of hla. On the other hand,
the macrolide erythromycin and several aminoglycosides reduced,
while FQs slightly stimulated hla expression and an almost
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complete inhibition of alpha-toxin expression was obtained using
clindamycin. Furthermore, methicillin enhanced Hla produc-
tion of both MSSA (methicillin-sensitive Staphylococcus aureus)
and MRSA (methicillin-resistant Staphylococcus aureus; Ohlsen
et al., 1998). The sub-inhibitory concentration of ceftazidime (β-
lactam) and ciproﬂoxacin (FQ) appeared to be effective in decreas-
ing the expression of a range of quorum sensing (QS)-regulated
virulence factors (Skindersoe et al., 2008).
Genomic rearrangements in pathogenic strains of Escherichia
coli and Shigella following exposure to sub-inhibitory concentra-
tions of kanamycin and ampicillin was demonstrated (Pedro et al.,
2011). Some of the rearrangements may engender genotypes with
increased virulence. SOS response, induced by ciproﬂoxacin, was
found to stimulate transfer of pathogenicity Island in Staphylo-
coccus aureus (Ubeda et al., 2005). Thus antibiotic used for the
treatment of clinical infections may lead to the dissemination of
virulence in some cases.
ROLE OF ANTIBIOTICS IN HOST–PARASITE INTERACTION
Antibiotics have also been found to modulate host immune cell
response, mostly mediated by cytokines. There are ample evi-
dences of sub-inhibitory concentrations of antibiotics interference
with processes of host–parasite interactions such as phagocytosis,
adherence, and virulence. Antibiotics promote phagocytosis by
altering the surface properties of pathogens. Many clinical iso-
lates of Enterococcus faecium are resistant to neutrophil-mediated
phagocytosis but exposure of vancomycin-susceptible Enterococ-
cus faecium to quinupristin/dalfopristin at concentrations both
at either sub-inhibitory or suprainhibitory concentrations pro-
moted susceptibility to subsequent PMN (polymorphonuclear
leucocytes)-mediated phagocytosis. Vancomycin-resistant strains
on the contrary exhibited very little change in their binding toward
PMNs after antibiotic pretreatment (Herrera-Insúa et al., 1997).
Use of amoxicillin for the treatment of Haemophilus inﬂuenzae
in acute otitis media caused upregulation in the expression of
cytokines, interleukin (IL)-6, tumor necrosis factor-α, and IL-10
(Melhus, 2001).
ROLE OF ANTIBIOTICS IN SOS AND DNA REPAIR GENE EXPRESSION
The SOS response, a regulatory network present in most bacte-
ria is induced in response to DNA damage and has been shown
to promote stress-induced mutagenesis, virulence, and dissemina-
tion of antibiotic resistance speciﬁcally by horizontal gene transfer
(HGT). Beaber et al. (2004) showed that ciproﬂoxacin induced
transfer of theVibrio cholerae SXT integrative conjugative element
(ICE) was controlled by SOS through RecA-dependent cleavage
of the SXT encoded repressor SetR. SXT is a 100-kb ICE derived
fromV. cholerae that encodes genes for the resistance toward chlo-
ramphenicol, sulfamethoxazole, trimethoprim, and streptomycin
(Beaber et al., 2004). Even the induction of the CTX prophage
which encodes the cholera toxin is regulated by the SOS repres-
sor LexA in conjunction with the phage repressor rstR which is
also regulated by LexA (Quinones et al., 2005). In V. cholerae, the
recombination-mediated excisionof integron cassettewas induced
by SOS in response to different antibiotics (Guerin et al., 2009).
On the other hand, SOS-independent recombination between
divergent sequences either by RecBCD or RecFOR pathways
was demonstrated in Escherichia coli by quinolones (DNA-
damaging antibiotics) induced emergence of drug resistance
(López et al., 2007).
Fluoroquinolones at sub-MIC have been shown to upregulate
both the SOS and the methyl mismatch repair (MMR) path-
way genes in Staphylococcus aureus with different SOS response
and DNA repair-associated promoter-lux gene fusion construct
(Mesak et al., 2008). Upregulation of several genes involved in
the SOS response such as umuD, lexA, sbmC, and dinP was
demonstrated in Salmonella using sub-inhibitory concentrations
of quinolones. In addition, transcriptional regulators, genes puta-
tively associated with membrane integrity (spr), virulence (sicA),
and metabolism (plsB) were also affected (Yim et al., 2011). On
the contrary, it has also been shown that exposure of Streptococ-
cus pneumoniae to quinolones, aminoglycosides, and penicillin at
sub-inhibitory concentrations may result in increased mutability,
without the apparent involvement of SOS-response components
(Henderson-Begg et al., 2006; Cortes et al., 2008).
SOS response also enhances frequency of mutations. Hence
antibiotics which induce SOS response, contribute to the increase
in the frequency of resistant strains. Exposure to ciproﬂoxacin was
found to increase in the frequency of rifampicin-resistant mutants
of Streptococcus pneumoniae almost by ﬁvefold (Henderson-Begg
et al., 2006). Carbapenem resistance in Pseudomonas aeruginosa
was also found to be enhanced in presence of the same antibiotic
almost in the same order (Tanimoto et al., 2008).
Thus low antibiotic concentration regulates the transcription
of different genes in target bacteria while increasing higher con-
centration elicits a stress response and even higher concentration
is lethal. Therefore, it is apparent that these small molecule at a
sub-inhibitory concentration participate in a new form of signal-
ing network by binding to different cytoplasmic macromolecular
receptors such as ribosomes, and those involved in DNA repli-
cation, RNA transcription machinery, and cell-wall biosynthesis
(Ryan and Dow, 2008). These receptors were also identiﬁed earlier
as the inhibitory targets for the bioactive molecules at higher con-
centration. The cellular targets for the lethal and sub-inhibitory
concentration sometimes also differ thus implying that antibi-
otics are multi-ligand-speciﬁc sensor molecules targeting dif-
ferent ligands in a concentration-dependent manner (Hoffman
et al., 2005).
ANTIBIOTICS AND QUORUM SENSING
Quorum sensing is a mode of bacterial communication in
response to release of chemical messenger which regulate bac-
terial gene expression (Bassler, 1999). Secondary metabolites are
activated during slow growth in the stationary phase and trig-
ger the transition from primary to secondary metabolism (Bibb,
2005). This transition is a complex process and involves many
signals, including those by small signaling molecules called γ-
butyrolactones (also known as autoregulatory factor or A-factor).
These signaling molecules, found mainly in Streptomyces species,
are considered “bacterial hormones” or the QS factor. The QS
signaling network initiates a set of metabolic changes leading to
a number of events including morphological differentiation and
synthesis of secondary metabolites such as antibiotics. The γ-
butyrolactones constitute the major group of QS molecules in
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bacteria. The ﬁrst γ-butyrolactone, A-factor, was identiﬁed in
Streptomyces griseus in 1967 (Hsiao et al., 2009).
Biosynthesis of γ-butyrolactones is not well understood, but
seems to be mediated by γ-butyrolactone synthase AfsA. The A-
factor (2-isocapryloyl-3R-hydroxymethyl-γ-butyrolactones), at a
certain critical concentration, binds to cytoplasmic receptor pro-
tein, a dimer of ArpA,whichprimarily acts as repressors by binding
to the promoter region of adpA (A-factor-responsive transcrip-
tional activator, a key pleiotropic regulator). The binding of the
A factor dissociates ArpA from the promoter, thus facilitating
the transcription and translation of adpA. Subsequently, AdpA
binds an upstream activation sequence to initiate the transcrip-
tion of strR (a pathway-speciﬁc regulatory gene responsible for
transcription of other streptomycin biosynthetic genes cluster).
strR is a pathway-speciﬁc regulator which acts as a transcriptional
activator and induces transcription of most of the streptomycin
biosynthetic genes by binding multiple sites in the gene cluster
(Retzlaff and Distler, 1995). Thus onset of streptomycin biosyn-
thesis is initiated by the QS factor, γ-butyrolactones. The gene
aphD, encoding a major streptomycin resistance determinant
streptomycin-6-phosphotransferase, is also under the control of
the adpA-dependent promoter. The binding to γ-butyrolactones
thus induces expression of the target genes (transcription fac-
tors) many of which are involved in regulation of speciﬁc
antibiotic biosynthesis clusters. Onset of streptomycin biosyn-
thesis is initiated by the QS factor, γ-butyrolactones (Retzlaff
and Distler, 1995). The expression of the gene aphD, encoding
a major streptomycin resistance determinant streptomycin-6-
phosphotransferase, is also a QS-mediated event. Each receptor
protein is highly speciﬁc for its cognate γ-butyrolactone. In
Erwinia carotovora carbapenem biosynthesis is regulated by a clas-
sical autoinducer N-(3-oxohexanoyl)-L-homoserine. In another
cephamycin C-producing bacterium, Streptomyces clavuligerus,
antibiotic synthesis is regulated at the primary regulatory level
by γ-butyrolactone (Liras et al., 2008).
Some 10–11 probable γ-butyrolactone synthates, all from
the Streptomyces genus were found while 37–42 putative γ-but-
yrolactone receptors were found in the genome of different other
bacteria apart from Streptomyces. Thus, it is believed that many of
the cellular activities including the antibiotic production is under
the control of a well-orchestrated QS signaling network mediated
by a small population of γ-butyrolactone producers acting as a
signaling factor for a diverse population of signal recipient
(Aminov, 2009).
Structural similarity between antibiotic and intracellular sig-
naling molecule has also been evidenced in several cases. The
quinolones produced by Pseudomonas aeruginosa have a wide
range of activities starting from antibiotics to autoinducers. 2-
Heptyl-3-hydroxy-4-quinolone (pseudomonas quinolone signal;
PQS), belonging to the family of 2-alkyl-4-quinolones (AQs), was
previously described for their antimicrobial activities. Later on, it
was found that PQS is integrated within an intricate QS circuit and
plays an important role in Pseudomonas aeruginosa pathogenesis
by regulating the production of diverse virulence factors including
elastase, pyocyanin, andLecA lectin in addition to affecting bioﬁlm
formation (Dubern and Diggle, 2008; Heeb et al., 2011). Several
other autoinducers likeN-(3-oxododecanoyl) homoserine lactone
and its tetrameric acid degradationproduct inPseudomonas aerug-
inosa have antibacterial properties against Gram-positive bacteria
(Kaufmann et al., 2005). N-(3-oxododecanoyl) homoserine lac-
tone and other 3-oxo series homoserine lactones with 8, 10, and
14 length carbon chains were shown to inhibit growth of the
Gram-positive Staphylococcus aureus (Qazi et al., 2006).
ANTIBIOTIC RESISTANCE, THE TIP OF THE ICEBERG
In the late 1960s, the unprecedented successes of early antibiotic
therapies led US Surgeon General William H. Stewart to make the
famous declaration: “it is time to close the book on infectious dis-
eases and declare the war against pestilence won” (Spellberg et al.,
2008). The euphoria did not last long and the magic bullets started
losing the efﬁcacy because of the steady emergence of antibiotic-
resistant pathogens simultaneously with their widespread use.
Following the success of penicillin in controlling bacterial infec-
tion among the soldiers during the Second World War, emergence
of penicillin-resistant strain was evidenced in the 1940s. By 1960,
it assumed the shape of a pandemic problem. New β-lactam
antibiotics were introduced into the clinical practice to restrain
the problem. Simultaneously bacterial strains resistant to them
came into being, a phenomenon dubbed as β-lactamase cycle. The
ﬁrst case of MRSA was identiﬁed in UK in 1961 (Johnson, 2011)
and the ﬁrst report on MRSA in the United States came in 1968.
Now it is prevalent all over the world. MRSA is actually resistant
to the entire class of penicillin-like antibiotics called β-lactams.
Presence of an enzyme called New Delhi metallo-β-lactamase
(NDM-1) in some Gram-negative bacteria (notably Escherichia
coli and Klebsiella pneumoniae) makes them resistant to virtually
allβ-lactams including carbapenems,which aremost often consid-
ered the last line of defense against multidrug-resistant pathogens
(Kumarasamy et al., 2010). Isolation of bacterial strains producing
extended spectrum β-lactamase (ESBL) resistant to third genera-
tion of cephalosporins and monobactams is also reported from
time to time (Kurihara et al., 2013).
The glycopeptide antibiotic vancomycinwas introduced in clin-
ical practice in 1958 for the treatment of methicillin resistance
in both Staphylococcus aureus and coagulase-negative staphylo-
cocci. Vancomycin resistance was so difﬁcult to induce that it was
believed to be very unlikely to occur in a clinical setting. Until the
late 1980s, the glycopeptide antibiotic vancomycin was considered
the drug of last resort for treatment of diseases caused by Gram-
positive bacteria such as Enterococcus faecalis,MRSA, Streptococcus
pneumoniae, and Clostridium difﬁcile (Cunha, 1995). However,
vancomycin resistance was ﬁrst reported in coagulase-negative
staphylococci in 1979 and 1983 (Srinivasan et al., 2002). At present
vancomycin-resistant enterococci (VRE) pose a major chal-
lenge in therapeutics. Multidrug-resistant tuberculosis (caused
by Mycobacterium tuberculosis) has assumed an epidemic pro-
portion in some parts of the world. Multidrug-resistant strains
of M. tuberculosis, now known to be present in 50 countries,
heighten the threat posed by untreatable and fatal human tuber-
culosis.
Because of the rapid dissemination of antibiotic resistance in
pathogens,manyof the antibiotics,whichwere highly effective ear-
lier, became obsolete during the past few decades. The efﬁcacy of
antibiotic treatment is on thewane as a result of the emergence and
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disseminationof antibiotic resistance amongst the pathogens. This
warrants the discovery of newer and more promising antibiotics
with long-term efﬁcacy against various life threatening infections.
However, the steady discovery of antibiotics witnessed during
1940–1980 could not be sustained. In the last two decades, only
one new antibiotic class viz the oxazolidinone was introduced in
the year 1990 and all other entrants were just the variation of
the existing one (Raghunath, 2008). Eventually, clinical manage-
ment of antibiotic-resistant superbugs is assuming the shape of
a gruesome problem because of the depleting antibiotic reserve
(Norrby et al., 2005). The widespread apprehension that we might
be heading to a situation similar to the pre-antibiotic era cannot
be dismissed as a far-stretched imagination.
Imprudent and excessive use of antibiotics is highlighted as a
major causative factor behind the setback. The idea dubbed as
Antibiotic Paradox by Levy (1992) is corroborated by numerous
evidences. In 1967, the ﬁrst penicillin-resistant Streptococcus pneu-
monia was observed in Australia, and after 7 years another case
of penicillin-resistant Streptococcus pneumonia was reported from
the U.S. in a patient with pneumococcal meningitis (Doern et al.,
2001). In 1980, 3–5% of Streptococcus pneumonia was estimated
to be penicillin-resistant and by 1998, 34% of the Streptococcus
pneumonia sampled was resistant to penicillin (Doern et al., 2001).
Antibiotic resistance in other organisms reﬂects the same trend as
observed in Streptococcus pneumonia against penicillin. Tetracy-
cline resistance by normal human intestinal ﬂora exploded from
2% in the 1950s to 80% in the 1990s (Shoemaker et al., 2001).
Kanamycin, an antibiotic used in the 1950s, has become clini-
cally obsolete as a result of the prevalence of kanamycin-resistant
bacteria (e.g., M. tuberculosis, Campylobacter jejuni).
On the other hand, it is also a fact that antibiotic resistance is
observed even in bacteria isolated from totally uninhabited and
thinly populated places, where they are unlikely or least likely to
come in contact with the antibiotics (Chattopadhyay andGrossart,
2010). It is evident that antibiotic resistance is an outcome of evo-
lution and pre-exposure of microorganisms to antibiotics is not a
pre-requisite for emergence of resistance. In a systematic analysis,
the conjugative plasmids occurring in several bacteria belonging to
Enterobacteriaceae obtained from Murray collection were found
to belong to the same incompatibility group as those present in
contemporary Enterobacteriaceae (Datta and Hughes, 1983). It
was shown that emergence and spread of conjugative plasmids,
which are known to be a major vehicle for transmission of resis-
tance,were not fostered by thewidespreaduse of antibiotics, rather
these plasmids evolved by inclusion of resistance-conferring genes
in pre-existing plasmids (Datta and Hughes, 1983; Hughes and
Datta, 1983).
Despite intensive investigations continuing for the last few
decades in a global scale, no signiﬁcant achievement has been
made so far in the prevention and control of resistance develop-
ment. A recent database reveals the existence of more than 20,000
potential resistance genes of nearly 400 different types in the avail-
able bacterial genome sequences. The fact that the number of
functional resistance determinants in pathogens is much smaller
(Liu and Pop, 2009) provides no relief since the new generation of
therapeutically useful antibiotics are reaching the market only in
trickle.
The World Health Organization (WHO) has long recognized
anti microbial resistance (AMR) as a growing global health threat,
and the World Health Assembly, through several resolutions over
two decades, has called upon Member States and the international
community to take measures to curtail the emergence and spread
of AMR.
EMERGENCE OF RESISTANCE PHENOTYPE
Antibiotic resistance is known to occur both in the pre-antibiotic
and antibiotic-era. The pre-antibiotic era constitutes the time
before the introduction of sulphonamides in 1930. It is well
established that resistance phenotype and the antibiotics in the
pre-antibiotic era coexisted in the natural environment with-
out facilitating the process of selection of the deadly resistant
pathogens.
The antibiotic era started following its discovery of antibiotics
and their use in different spheres of life. The use of high concen-
tration of lethal dose of antibiotics as a consequence of human
activity led to a major change in innate functional role to give
rise to the emergence of antibiotic-resistant pathogens within a
short span of time. Antibiotic resistance genes, which were once
involved in other cellular functions before human intervention,
have been subsequently selected for the resistance phenotype with
increased use of antibiotics. They have been mobilized from the
environmental genomic reservoirs, with the rapid dissemination
into taxonomically divergent commensal and pathogenic bacte-
ria. Metagenomic approach in conjunction with a pipeline for
the de novo assembly of short-read sequence data from func-
tional selections (termed PARFuMS) has shown the evidence of
lateral transmission of ﬁve different antibiotic resistance genes
along with different non-coding region as well as multiple mobi-
lization sequences from environmental reservoir of soil bacteria
to the clinical pathogens (Forsberg et al., 2012). Thus HGT or
lateral gene transfer, which contributes signiﬁcantly to the evolu-
tion, maintenance, and transmission of virulence in pathogenic
bacteria, also plays a pivotal role in dissemination of antibi-
otic resistance conferring genes from the environment in clinical
settings (Colomer-Lluch et al., 2011).
Epigenetic inheritance-based evolution of antibiotic resistance
genes has been reported in an isogenic population of Escherichia
coli, exposed to gradually increasing concentration of different
antibiotics such as ampicillin, nalidixic acid, and tetracycline. The
high frequency of survival on low antibiotic concentration could
not be accounted for by the occurrence of random spontaneous
mutation. Instead it suggested that the antibiotic resistance genes
were acquired by epigenetic inheritance. High reversion of this
resistance phenotype further proved that it was indeed a case of
epigenetic inheritance which does not impart a stable phenotype
due to maintenance of certain chromatin conﬁguration or DNA
methylation state (Adam et al., 2008).
There are ample evidences to suggest that anthropogenic fac-
tors (use of antibiotics by human both for therapeutic and
non-therapeutic purposes and disposal of the unused antibiotic
formulations) inﬂict signiﬁcant changes on the natural ﬂora of
bacteria. But the actual concentrations of antibiotics (and other
pharmaceuticals) that bacteria in thenatural population is exposed
to, remain unknown in most of the cases (Kümmerer, 2003, 2004).
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy March 2013 | Volume 4 | Article 47 | 6
“fmicb-04-00047” — 2013/3/12 — 11:18 — page 7 — #7
Sengupta et al. Ecological role of antibiotics in nature
Its role in the emergence of antibiotic resistance still remains highly
controversial (Bhullar et al., 2012).
In therapeutics, the pathogens are challenged with an over-
whelmingly high concentration of a single or few antibiotics
whereas the soil borne microbes exist in a complex microenvi-
ronment and encounter a number of simultaneously occurring
stress factors in a network of multiple interactions. Probably,
these interactions have a nullifying effect on each other thus
favoring the evolutionary selection of antibiotic sensitivity over
resistance (Chait et al., 2011). Therefore, the dynamics of antibi-
otic resistance in clinical settings is believed to be inﬂicted by
anthropocentric factors and is quite different fromnaturally occur-
ring resistance. Simulation of these natural niches may reveal the
dynamics by which antibiotic resistance is disseminated across the
microbial population.
IMPLICATION OF SUBLETHAL CONCENTRATIONS OF
ANTIBIOTICS IN DISSEMINATION OF RESISTANCE
In nature, sub-inhibitory concentrations of antibiotics are prob-
ably encountered by bacteria more frequently than inhibitory
concentrations. Most often bacteria are exposed to antibiotics
at a sublethal concentration in certain clinical situations such as
incomplete treatment of an infection, patient non-compliance,
and reduced or limited drug accessibility to certain tissues (e.g.,
bone or cerebrospinal ﬂuid; Bryskier, 2005). In the colon of a
person taking antibiotics, sub-inhibitory concentrations would be
experienced by colonic bacteria during the initial phase of treat-
ment and at the end of treatment. Thus host tissues are exposed
to a range of drug concentration starting from higher to a sub-
inhibitory concentration. Therefore,micro-nicheswithin the host,
such as epidermis, lungs, and joints, may attain signiﬁcantly lower
drug concentrations than the plasma (Rybak, 2006). Outside clin-
ical settings, sub-inhibitory condition is established because of the
use of manure from livestock whose feed is supplemented with
antibiotics and in consequence multiple drugs in a very low level
ﬁnd their way both to the soil and aqueous environment.
Due to such imprudent use of antibiotics, bacteria are quite
likely to experience sublethal levels of antibiotics which have high
implications in the spread of multidrug resistance. There is evi-
dence that low level of antibiotics gives rise to mutagenesis in
a wider range of antibacterial resistance genes and drug efﬂux
systems resulting in multidrug resistance (Girgis et al., 2009). Sub-
inhibitory concentrations of β-lactams were found to enhance the
transfer of tetracycline resistanceplasmids in Staphylococcus aureus
by up to 1,000-fold (Barr et al., 1986). Ampicillin treatment of
Escherichia coli was associated with the formation of norﬂoxacin-
resistant isolates with mutations in gyrA, gyrB, or the acrAB
promoter (PacrAB) and kanamycin-resistant isolates with muta-
tions in rpsL or arcA (A and B). It has been hypothesized that low
level of bactericidal antibiotics give rise to reactive oxygen species
(ROS) which leads to DNA damage-induced mutations thus facil-
itating the emergence of multidrug-resistant bacteria (Kohanski
et al., 2010). Induction of prophage in animal feed by antibiotics
was evidenced. It may contribute to dissemination of antibiotic
resistance (Allen et al., 2011). Induction of shigella toxin-encoding
bacteriophage by ciproﬂoxacin and enhanced Shiga toxin (Stx)
production from Escherichia coli O157:H7 was demonstrated in
vitro and in vivo. Hence antibiotic-induction of phage may also
contribute to increased virulence (Zhang et al., 2000).
In many cases, exposure to a low-dose antibiotic is associ-
ated with mobile element-mediated dissemination of antibiotic
resistance genes through HGT which is known to be enhanced
by sub-MIC concentrations of tetracycline (Celli and Trieu-Cuot,
1998). Tetracycline at a sub-inhibitory concentration in themating
medium substantially enhanced Tn916 mediated conjugal trans-
fer to the recipient Bacillus thuringiensis subsp. israelensis (Showsh
andAndrews, 1992). Spread of antibiotic resistance genes between
human colonic Bacteroides spp. is mediated by self-transmissible
elements known as conjugative transposons (CTns). The expo-
sure of donor Bacteroides cells to low concentration of tetracycline
appeared to be a pre-requisite for the excision of the CTnDOT
family of CTns from the chromosome and conjugal transfer of the
excised elements. Virtually no transfer occurs without the tetracy-
cline induction of donor cells (Stevens et al., 1993; Whittle et al.,
2002). Low concentrations of tetracyclinemight increase the likeli-
hood of HGTof integratedmobile elements, such asCTnDOTand
NBU1. At sub-inhibitory tetracycline concentration, the excision
is not associated with growth phase (Song et al., 2005). Mobi-
lization of coresident non-conjugative plasmids (from Bacteroides
strain to Bacteroides strain or Escherichia coli) by chromosoma-
lly encoded tetracycline conjugal elements (Valentine et al., 1988)
was enhanced by 20–10,000-folds when the donor was pre-grown
in a sub-inhibitory concentration of tetracycline (1 μg/ml). The
similar stimulatory effect of tetracycline on conjugation trans-
fer was also demonstrated for the conjugative transposon Tn925
(Torres et al., 1991).
These in vitro observations were validated in vivo in gnoto-
biotic mice where tetracycline at a sublethal concentration in
drinking water could induce the frequency of conjugative trans-
fer of the transposon Tn1545 from Enterococcus faecalis to Listeria
monocytogenes in the digestive tract and there was an approxi-
mately 10-fold increase in the transposition (Doucet-Populaire
et al., 1991). In gnotobiotic rats, selection for the resistant phe-
notype was the major factor causing higher numbers of Tn916
transconjugants in the presence of tetracycline (Bahl et al., 2004).
Therefore, the enhancement of conjugal transfer of antibiotic
resistance-carrying transposons in the presence of sub-inhibitory
concentration of antibiotics is not only an in vitro phenomenon
but also takes place in the human intestinal microbiome of animal
models.
Adverse effect of some antibiotics on bacterial motility was
reported earlier (Molinari et al., 1992; Kawamura-Sato et al.,
2000). However, sub-inhibitory concentration of tobramycin was
observed to increase motility of Pseudomonas aeruginosa and
enhance the expression of virulence determinants of the organism
(Linares et al., 2006).
ANTIBIOTIC RESISTANCE AND ITS ROLE IN NATURE
Antibiotic resistance can be deﬁned in different ways: from the
microbiological point of view, the resistance is deﬁned as a pheno-
type which makes the microorganism less susceptible than other
members of the same species irrespective of any level of resistance.
On the contrary, when the resistance reaches a certain critical level
so as to interfere with the pharmacotherapy of a clinical problem
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caused by the bacterium, it is called clinical resistance (Cantón and
Morosini, 2011).
In thepresent scenario, acquired clinical resistanceof pathogens
is a major concern in the healthcare management which results
from genetic changes involving mutation or HGT. Besides
acquired resistance dealt with in this article, some other types
of antibiotic resistances are also observed in bacteria. For example
in some cases tolerance of a bacterium to a certain antibiotic is
dependent on its metabolic state. It exhibits susceptibility to the
antibiotic in growing state but become resistant to the same antibi-
otic in stationary phase. The micro-environments in a bioﬁlm
also contribute to the differential susceptibility of bacteria embed-
ded in different parts of the polysaccharide matrix. Swarming, a
phenomenon induced in some bacteria in response to nitrogen
limitation, confers resistance to some antibiotics (Martinez and
Rojo, 2011). Resistance to a variety of antibiotics was observed in
swarming cells of some bacteria. This observation together with
the resistance observed in bioﬁlm clearly indicates that antibiotic
resistance is a manifestation of social behavior of bacteria (Lai
et al., 2009). Accumulation of the alarmone (p) ppGpp was also
reported to modulate antibiotic resistance. Involvement of this
alarmone in persistence (resistance occurring in a small fraction
of naturally occurring bacteria) is postulated (Jayaraman, 2009).
This type of resistance, known as phenotypic resistance, signiﬁ-
cantly contributes to some problems in clinical management of
some bacterial infections.
The most ancient resistance also known as intrinsic resistance
(Sheldon, 2005) is species-speciﬁc and results from impermeabil-
ity of the cells to the antibiotic or lack of target of an antibiotic to a
certain organism. However, besides these passive factors, intrinsic
resistance is also caused by some antibiotic-detoxifying deter-
minants encoding chromosomally encoded β-lactamases, efﬂux
pumps or target-protecting proteins. This antibiotic resistance is
widespread in nature and this huge intrinsic resistome of bacte-
ria consists of genes of varied phylogenetic origin This intrinsic
resistome has a high degree of non-speciﬁcity and many of the
proteins encoded by these genes are involved in the basic phys-
iological functions in the natural ecosystem as demonstrated in
Pseudomonas aeruginosa, the novel nosocomial Gram-negative
pathogen of environmental origin (Fajardo et al., 2008). The pres-
ence of antibiotics acts as a switch in physiological function to
the antibiotic-resistance phenotype. These resistance genes per-
sist in bacteria even in antibiotic-free environment thus further
substantiating their alternative role in bacterial physiology. Tet(L)
and Tet(K), the speciﬁc tetracycline c-resistance determinants are
known to catalyze Na+ and K+ exchange for protons (Krulwich
et al., 2001). Tet(L), a tetracycline-efﬂux transporter, and MdfA, a
multidrug-efﬂux transporter, both responsible for alkali tolerance
offer a striking example in support of this hypothesis (Krulwich
et al., 2005). In M. tuberculosis the P55 efﬂux pump plays an
important role in oxidative stress response and in vitro cell growth
in addition to contributing to its intrinsic resistance phenotype
(Ramón-García et al., 2009).
It is obvious that bacteria evolve with antibiotic resistance
determinants get selective advantage over their antibiotic-sensitive
counterparts in presence of antibiotics. However, some of the
multidrug resistance determinants confer resistance not only
to antibiotics but also to a number of structurally unrelated
compounds viz, ethidium bromide, quaternary ammonium com-
pounds, the DNA-intercalating mutagen acridine, the anionic
detergent sodium dodecyl sulfate and uncouplers. Hence they
appear to have a greater role in bacterial physiology. They
also confer resistance to some chemical substances produced by
the host, e.g., bile acids. It is speculated that antibiotic resis-
tance is an offshoot of some hitherto undeﬁned physiological
roles played by the determinants in these bacteria (Martinez and
Rojo, 2011).
Most antibiotic-producing strains carry genes encoding resis-
tance to the antibiotics that they produce (Hopwood, 2007; Tahlan
et al., 2007) and these genes are usually found in the same gene
cluster as the antibiotic biosynthesis pathway genes (Benveniste
and Davies, 1973; Martin and Liras, 1989). The proximity of the
antibiotic resistance gene with the antibiotic biosynthetic gene as
evidenced in Streptomyces coelicolor (where the genes encoding
export proteins are embedded in the actinorhodin biosynthesis
pathway) led to the postulation that these resistance determinants
could have some role in the biosynthetic pathway of antibiotics
(Allen et al., 2010). Antibiotic resistance genes are frequently
present even in non-producer strains (Yamashita et al., 1985). In
consequence, bacteria have evolved with a diverse pool of genes
(the “resistome”) that protect them against the therapeutic dose
of antibiotics. Gene orthologous to these have been identiﬁed on
mobile genetic elements in resistant pathogens in clinical settings.
These genes that make up this environmental resistome have the
potential to be transferred to pathogens and indeed there is some
evidence that at least some clinically relevant resistance genes have
originated in environmental microbes (Wright, 2010).
ANCIENT ORIGIN OF ANTIBIOTIC RESISTANCE GENES
It is well-established documented that the antibiotic resistance is a
long-evolved trait in prokaryotes and the diverse pool of resistant
genes co-evolved with antibiotics in non-clinical (natural) envi-
ronment much before these have been used in human therapy.
Most of the antibiotic producer organisms carry the respective
antibiotic resistance genes and both the resistance and the antibi-
otic biosynthesis pathway genes are usually found in the same gene
cluster (Allen et al., 2010).
In the evolutionary scale many antibiotics or their structurally
related precursors are believed to be as old as amino acids. It has
been suggested that antibiotics aremore than 500million years old,
dating back to the Cambrian period and probably evolved at the
same time vertebrate ﬁsh emerged (Baltz, 2008). The components
of the antibiotics are believed to be even older and the postulation
is substantiated by the occurrence of non-protein amino acids
of peptide antibiotics in meteorites and other primordial sources
(Johnson et al., 2008). Julian Davies at the University of British
Columbia proposes that antibiotics could be some of the oldest
biomolecules (Amábile-Cuevas, 2003).
Metagenomic analyses of ancient DNA from 30,000-year-
old to Beringian permafrost sediments dating back to the late
Pleistocene age demonstrated the presence of different antibi-
otic resistance genes encoding resistance to β-lactam, tetracycline,
and glycopeptide antibiotics (D’Costa et al., 2011). Structural and
functional studies of oneof these ancient resistance genes, the vanA
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(vancomycin resistance operon) that encodes an ATP dependent
D-alanyl-D-lactate ligase conﬁrmed that it is essentially indistin-
guishable fromVanA ligase associated with the recently discovered
vancomycin resistance in the clinic.
Very recently, Lechuguilla Cave in New Mexico, cut off from
the human activity for over four million years, was found to
harbor culturable microbiomes, highly resistant to antibiotics.
Some strains were found to be resistant to as many as 14 differ-
ent commercially available antibiotics. Resistance was detected to
a wide range of structurally different antibiotics including dap-
tomycin, an antibiotic of last resort in the treatment of drug
resistant Gram-positive pathogens. Enzyme-mediated mecha-
nisms (e.g., glycosylation, phosphorylation) leading to resistance
against both natural and semi-synthetic antibiotics were also dis-
covered in some ancient bacteria. Characterization of macrolide
kinase obtained from one of these resistant organisms revealed
it to be related to a known family of kinases circulating in drug
resistant pathogens at present (Bhullar et al., 2012).
In another study, molecular analysis of a metagenomic library
from the cold-seep sediments of the deep sea Edison seamount
(about 10,000 years old) also demonstrated the presence of TEM-
type ESBLs (TEM-1 and TEM-116) suggesting that β-lactam
resistance in microorganisms is likely to be present prior to the
modern antibiotic era, and the diversity of TEM β-lactamases
is not a recent phenomenon, rather it is the result of a very
ancient evolution (Song et al., 2005). Therefore, despite the fact
that increase in the use of an antibiotic is directly associated
with increase in the frequency of resistant strains, it is obvi-
ous that exposure to antibiotics is not a pre-requisite for the
emergence of resistance. Even the diversiﬁcation of the antibiotic
resistance appears to occurmuchbefore the human intervention as
evidenced by the occurrence of the TEM-type ESBL in the 10,000-
year-old sediments of the Edison seamount. But the prevalence
of the resistance bacteria having TEM-1 and TEM-116 was as low
as 0.3% (25 of 8,823) and 0.06% (5 of 8,823), respectively (Allen
et al., 2009). Recent investigations revealed that the origin of both
antibiotic resistance and the biosynthetic genes date back to the
ancient period much before the human civilization began. Both
antibiotics and the resistance phenotype existed together in nature
for a long time.
There are many other cases of occurrence of antibiotic resis-
tance genes in apparently antibiotic-free environments. The
metagenomic studies of remote Alaskan soil revealed the presence
of divergent β-lactamase genes and a bifunctional β-lactamase
(Allen et al., 2009). These β-lactamases are more closely related
to ancestral homologs compared to those isolated in clinical set-
tings and are capable of conferring resistance on Escherichia coli
despite the evolutionary distance. In another example of antibiotic
resistance in environments not impacted by antibiotics, the phe-
notype of more than 60% of the Enterobacteriaceae isolates from
a pristine freshwater environment was found to be multidrug-
resistant. An example of this evidence exists in the two strains of
Citrobacter freundii that were collected prior to the antibiotic era
(the 1920s) which carried ampC β-lactamase genes. The encoded
AmpC β-lactamases were as active as the recent plasmid borne
AmpC β-lactamases (class C) that were found in the antibiotic era
(Barlow and Hall, 2002). Phylogenetic analysis of the genetically
diversiﬁed serine β-lactamases suggests an ancient root for the
antibiotic resistance genes (Hall and Barlow, 2003).
Even the Murray collection (procured before and after the
introduction of antibiotics, i.e., between 1917 and 1952) exhibited
ampicillin and tetracycline resistance in 11 out of 433 enterobacte-
rial strains and the resistance was non-conjugative. These studies
reveal that the determinants of antibiotic resistance existed in
naturemuch before the human intervention. Millions of years ago,
antibiotics and antibiotic biosynthetic pathways evolved suggest-
ing that both antibiotics and the resistance genes are very ancient
(Wright and Poinar, 2012). The presence of multidrug-resistant
organisms even in this pristine environment reinforces the idea
that the antibiotic resistome is ancient and omnipresent in the
microbial genome.
CAN THE DOOMSDAY BE POSTPONED?
In keeping with a policy package recommended by WHO in 2002
emphasis was given on the availability of proper facilities to ensure
rapid testing of antibiotic resistance, regular documentation and
sharing of the surveillance data, uninterrupted access to quality
medical service, regulation on the sale of antibiotics, development
of new diagnostic tests, and novel antimicrobials. But the problem
continues to be unabated till now (Leung et al., 2011).
Recently, scientists (Marrafﬁni and Sontheimer, 2008) from the
NorthwesternUniversity have discovered a speciﬁcDNA sequence,
called a CRISPR (clustered, regularly interspaced, short palin-
dromic repeat) locus, which confer prokaryotes a type of acquired
immunity against the acquisition of resistance genes by encoding a
sequence-speciﬁc defense mechanism against bacteriophages and
thus conferring an immunity toward HGT. Members of recently
potentially virulent strains of enterococcal have been shown to lack
complete CRISPR loci. Expression of the CRISPR interference has
also been found to prevent the transfer of antibiotic resistance and
virulent genes, not only in vitro, but also in vivo, during a pneu-
mococcal infection (Bikard et al., 2012). “If this mechanism could
be manipulated in a clinical setting, it would provide a means to
limit the spread of antibiotic resistance genes and virulence fac-
tors in Staphylococcus and other bacterial pathogens,” hopes Erik
Sontheimer, Associate Professor at the Weinberg College of Arts
and Sciences.
The new Eco-Evo drugs and strategies target prevention of the
evolution and emergence of resistant bacteria in the environment.
This might be achieved by using inhibitors against four P’s viz,
penetration (by using 7-valent conjugated vaccine, PC7 to prevent
colonization of resistant serotype in human), promiscuity (using
broad host range conjugation inhibitor), plasticity (recombinase
inhibitor), and persistence (decontamination of high risk clones
or mobile genetic elements) of resistant bacteria. This strategy
appears implementable in viewof the fact that preventivemeasures
recommended in various steps are mostly adoptable. However,
their long-term impact on the environment warrants rigorous
testing before implementation (Baquero et al., 2011). In order to
combat the looming crisis, a number of different other approaches
have been adopted. Pharmaceutical companies are tapping new
sources (samples obtained from tropical rain forests, myxobac-
teria, marine bacteria, extremophilic bacteria) for novel antibi-
otics. Development of antimicrobials against bacterial molecules,
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which were not targeted earlier (e.g., bacteria DNA polymerase
III, the cell division protein FtsZ, ﬁbronectin binding proteins)
is aimed at. Genes indispensable for survival of pathogens are
shortlisted in search of new targets. In another strategy, molecular
techniques are beingused to clone the antibiotic biosynthetic genes
cluster of a strain into a different strain, ultimately to get a hybrid
molecule with antibiotic activity. In another approach called
directed evolution, libraries are developed with randomly mixed
and matched gene clusters obtained from different antibiotic pro-
ducer strains. These libraries are transformed into protoplasts
and recombinants are screened for improved spectrum of antibi-
otic activity. Large number of new compounds synthesized on
a solid support, are screened for activity in another technique
called combinatorial chemistry. These new strategies are expected
to generate new compounds with novel antimicrobial activities
(Strohl, 1997).
Several secondary approaches like reduction of antibiotic con-
sumption, preservation of existing therapeutics, development of
new antibiotics, and development of new strategies like sensiti-
zation of pathogens (Toney et al., 1998) have been adopted. The
formulation, augmentin, a combination of β-lactamase inhibitor
(clavulanic acid) and amoxicillin, is being successfully used against
a variety of penicillin-resistant pathogens.
CONCLUSION
It is apparent that antibiotics are endowed with multifaceted
activities and the cell modulates their role. The dual nature of
antibiotic acting both as signaling molecule as well as growth
inhibitory molecule suggests that antibiotic resistance genes have
to co-evolve with antibiotics to safe guard the producer organism
from antibiotic threat.
While it is obvious that dissemination of resistance-conferring
genes has been facilitated following introduction of antibiotics
into the clinical practice, we are yet to get sufﬁcient evidence to
conclude that human intervention is the only contributing fac-
tor behind the spread of resistance. Until and unless we generate
required amount of information to ﬁll up the gap of knowledge
in this aspect, we cannot expect to devise measures which would
effectively arrest the progress of the crisis.
Antibiotic resistance is a complex and continually evolving
problem. A vast body of information has been engendered during
the past 70 years on the antibiotic resistance and its dissemina-
tion. Comparative genomics, molecular genetics, combinatorial
chemistry, and structural biology are being applied to explore new
antibiotics but still the struggle is on. Several secondary approaches
like reduction of antibiotic consumption, preservation of existing
therapeutics, development of new antibiotics, and development of
new strategies like sensitization of antibiotic-resistant organisms
using QS inhibitors have been adopted but without much success.
Relatively rare genes that happened to confer antibiotic resis-
tance were once involved in other cellular functions, but were
selected for the resistance phenotype and mobilized from the envi-
ronmental genomic reservoirs, with the rapid dissemination into
taxonomically divergent commensal and pathogenic bacteria. This
process was very rapid on an evolutionary scale and HGT, medi-
ated by mobile genetic elements, played a prominent role in it. So
it would be wise to plan a strategy to control the process of HGT
to control subsequent transfer of resistance genes to pathogens.
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